Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma

Abstract

This open study suggests that intranasal lysine-aspirin administration reduces nasal polyp volume in aspirin-intolerant patients, without any adverse affect on concomitant asthma. This was a preliminary study and should be followed by a placebo-controlled, double-blind trial.